UK AI Health Data Sharing: Conditional Support Found

Public willingness to share personal health data for medical research, particularly involving artificial intelligence (AI), isn’t a simple yes or no. A new study from the United Kingdom reveals that support is conditional, hinging on perceptions of clear public benefit, robust data security, and genuinely informed consent. The findings, published in BMJ Digital Health & AI, underscore the complexities of building public trust in an era where data is increasingly seen as essential for medical advancement.

Researchers at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) conducted eight online focus groups with 41 adults across the UK. Participants represented a diverse range of ages, ethnicities, health experiences, and socioeconomic backgrounds. The study aimed to understand how individuals weigh the potential risks and benefits of sharing their health information in the context of AI development.

The discussions centered around realistic scenarios, including university-led research projects, large research databases, and collaborations with commercial companies. Participants weren’t asked about hypothetical situations; instead, they were presented with concrete examples to encourage thoughtful consideration. This approach, according to lead author Rachel Kuo, NIHR Doctoral Research Fellow, was crucial to understanding the nuances of public opinion. “AI is increasingly embedded in public consciousness, and there is rapid innovation in its use for healthcare,” Kuo explained. “However, developing and testing AI requires access to large volumes of patient data, which raises concerns about confidentiality and security. Our aim was to understand how people think about sharing their data in the context of AI, and whether AI introduces particular fears or perceived benefits that shape those decisions.”

The Importance of Anonymization and Security

A consistent theme throughout the focus groups was the critical importance of anonymization. Participants widely believed that removing personally identifiable information was essential before data could be used for research. However, they also expressed skepticism about the effectiveness of anonymization, particularly for individuals with rare conditions or when datasets are combined. The concern was that even without obvious identifiers, it might be possible to re-identify individuals through linked data.

Beyond anonymization, participants emphasized the need for strong safeguards to protect data from breaches and misuse. They wanted assurances that data would be stored securely and used only for the purposes they had been informed about. The study highlights a growing public awareness of the potential vulnerabilities of health data in the digital age.

Public Benefit Must Be Clear

While concerns about privacy and security were prominent, participants weren’t uniformly opposed to data sharing. In fact, many expressed conditional support, but only if they could clearly see a direct benefit to themselves or to society. The perceived benefit needed to be tangible and well-articulated. Vague promises of future medical breakthroughs weren’t sufficient to overcome concerns about risk.

The study suggests that public trust is more likely to be earned when data sharing is linked to specific research projects addressing pressing health challenges. For example, participants were more receptive to sharing data for research into rare diseases or for developing new treatments for conditions that directly affected them or their families.

Meaningful Consent is Key

The concept of consent emerged as a central theme. Participants stressed the importance of being fully informed about how their data would be used and having the ability to make a genuine, voluntary decision about whether or not to participate. They expressed concerns about overly complex consent forms or situations where they felt pressured to share their data.

Participants also highlighted the need for ongoing consent. They wanted the ability to withdraw their data from research projects at any time and to be informed of any changes in how their data was being used. This emphasis on control and transparency reflects a growing desire for greater autonomy over personal health information.

Broader Implications for Health Data Sharing

The findings from this UK study have broader implications for health data sharing initiatives worldwide. As AI continues to transform healthcare, the demand for large datasets will only increase. Building public trust will be essential to unlocking the full potential of AI while safeguarding individual privacy and autonomy.

The researchers emphasize the need for robust and transparent governance frameworks to oversee health data sharing for AI research. These frameworks should prioritize data security, ensure meaningful consent, and clearly communicate the benefits of data sharing to the public. Without such frameworks, public support for health data sharing could erode, hindering progress in medical innovation. The study adds to a growing body of evidence highlighting the importance of public engagement and ethical considerations in the development and deployment of AI in healthcare. Similar research conducted in Saudi Arabia, as reported by Frontiers, suggests concerns about the commodification of health data are not limited to a single country.

February 9, 2026, the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) released the study, adding to the ongoing conversation about responsible data use in the age of AI.